These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 36982154

  • 1. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.
    Makler A, Asghar W.
    Int J Mol Sci; 2023 Mar 07; 24(6):. PubMed ID: 36982154
    [Abstract] [Full Text] [Related]

  • 2. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
    Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, Kim S, Roe DJ, Darabi S, Han IW, Evans DB, Yamada S, Demeure MJ, Becerra C, Celinski SA, Borazanci E, Tsai S, Kodera Y, Park JO, Bolton JS, Wang X, Kim SC, Von Hoff D, Goel A.
    Gastroenterology; 2022 Nov 07; 163(5):1252-1266.e2. PubMed ID: 35850192
    [Abstract] [Full Text] [Related]

  • 3. An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.
    Makler A, Narayanan R, Asghar W.
    Biosensors (Basel); 2022 Oct 06; 12(10):. PubMed ID: 36290970
    [Abstract] [Full Text] [Related]

  • 4. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S, Sadakari Y, Ohtsuka T, Okayama T, Nakashima Y, Gotoh Y, Saeki K, Mori Y, Nakata K, Miyasaka Y, Onishi H, Oda Y, Goggins M, Nakamura M.
    Ann Surg Oncol; 2019 Jul 06; 26(7):2104-2111. PubMed ID: 30820789
    [Abstract] [Full Text] [Related]

  • 5. Exosomal miR-199a-3p Secreted From Cancer-Associated Adipocytes Promotes Pancreatic Cancer Progression.
    Noda K, Sato Y, Okada Y, Nishida K, Kawano Y, Tanahashi T, Bando M, Okamoto K, Takehara M, Sogabe M, Miyamoto H, Daizumoto K, Kanayama H, Takayama T.
    Cancer Med; 2024 Oct 06; 13(20):e70265. PubMed ID: 39431622
    [Abstract] [Full Text] [Related]

  • 6. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
    Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M.
    Cancer Lett; 2017 May 01; 393():86-93. PubMed ID: 28232049
    [Abstract] [Full Text] [Related]

  • 7. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA, Rashid S, Singh N, Rashid S, Singh V, Gunjan D, Das P, Dash NR, Pandey RM, Chauhan SS, Gupta S, Saraya A.
    Sci Rep; 2021 Feb 02; 11(1):2824. PubMed ID: 33531550
    [Abstract] [Full Text] [Related]

  • 8. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.
    Clin Transl Gastroenterol; 2019 Apr 02; 10(4):e00029. PubMed ID: 31009404
    [Abstract] [Full Text] [Related]

  • 9. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan J, Zou Y, Chen S.
    J Exp Clin Cancer Res; 2019 Jul 15; 38(1):310. PubMed ID: 31307515
    [Abstract] [Full Text] [Related]

  • 10. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S.
    Cancer Prev Res (Phila); 2021 Jul 15; 14(7):729-740. PubMed ID: 33893071
    [Abstract] [Full Text] [Related]

  • 11. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
    Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S, Korc M.
    Am J Gastroenterol; 2014 Dec 15; 109(12):1942-52. PubMed ID: 25350767
    [Abstract] [Full Text] [Related]

  • 12. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B, Izetti P, Gregório C, Macedo GS, Castro MA, Osvaldt AB, Matte U, Ashton-Prolla P.
    Pancreas; 2016 Jan 15; 45(1):84-92. PubMed ID: 26262588
    [Abstract] [Full Text] [Related]

  • 13. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W, Miao Y.
    Cancer Med; 2019 Jun 15; 8(6):2810-2822. PubMed ID: 31006985
    [Abstract] [Full Text] [Related]

  • 14. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ.
    Pancreatology; 2022 Jun 15; 22(5):626-635. PubMed ID: 35613957
    [Abstract] [Full Text] [Related]

  • 15. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
    Kandimalla R, Shimura T, Mallik S, Sonohara F, Tsai S, Evans DB, Kim SC, Baba H, Kodera Y, Von Hoff D, Chen X, Goel A.
    Ann Surg; 2022 Jan 01; 275(1):e229-e237. PubMed ID: 32398486
    [Abstract] [Full Text] [Related]

  • 16. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu X, Bhandari K, Xu C, Morris K, Ding WQ.
    Int J Mol Sci; 2023 Apr 13; 24(8):. PubMed ID: 37108374
    [Abstract] [Full Text] [Related]

  • 17. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA.
    Int J Cancer; 2012 Jul 15; 131(2):E86-95. PubMed ID: 21953293
    [Abstract] [Full Text] [Related]

  • 18. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G.
    Clin Transl Med; 2021 Sep 15; 11(9):e520. PubMed ID: 34586739
    [Abstract] [Full Text] [Related]

  • 19. Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico.
    Álvarez-Hilario LG, Salmerón-Bárcenas EG, Ávila-López PA, Hernández-Montes G, Aréchaga-Ocampo E, Herrera-Goepfert R, Albores-Saavedra J, Manzano-Robleda MDC, Saldívar-Cerón HI, Martínez-Frías SP, Thompson-Bonilla MDR, Vargas M, Hernández-Rivas R.
    Int J Mol Sci; 2023 Oct 14; 24(20):. PubMed ID: 37894871
    [Abstract] [Full Text] [Related]

  • 20. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.
    Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.